Related Experiment Video
Updated: Jul 17, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study
Medea Imboden1, Sara H Downs, Oliver Senn
1Institutes of Social and Preventive Medicine & Surgical Pathology, Molecular Epidemiology/Cancer Registry, University of Zurich & University Hospital Zurich, Switzerland. imboden@medgen.unizh.ch <imboden@medgen.unizh.ch>
Genetic Glutathione S-transferase (GST) gene deficiency, specifically GSTT1, is linked to faster lung function decline in men. This finding aids in understanding chronic obstructive pulmonary disease (COPD) risk factors.
Area of Science:
- Environmental and Genetic Epidemiology
- Pulmonary Medicine
- Toxicology
Background:
- Understanding environmental and genetic factors is crucial for preventing chronic obstructive pulmonary disease (COPD).
- Glutathione S-transferase (GST) gene deficiency has been linked to poorer lung function in specific populations.
- This study investigates GST gene variants' association with accelerated lung function decline in the general adult population.
Purpose of the Study:
- To assess the association between low activity variants in Glutathione S-transferase (GST) genes and accelerated lung function decline.
- To identify genetic risk factors for lung function decline in the general adult population.
- To explore potential prevention strategies for chronic obstructive pulmonary disease (COPD).
Main Methods:
- Prospective cohort study (SAPALDIA) with 4686 participants.
- Multiple regression analysis examined polymorphisms in GSTM1, GSTT1, and GSTP1 genes.
- Longitudinal assessment of lung function decline (FEV1, FVC, FEF25-75) over 11 years, with analysis of effect modification by smoking, gender, and other factors.
Main Results:
- GST genotypes showed associations with lung function decline, most consistently for FEV1 (Forced Expiratory Volume in 1 second).
- GSTT1 homozygous gene deletion, alone or with GSTM1 deletion, was associated with accelerated FEV1 decline in men, but not women.
- Men with combined GSTT1 and GSTM1 gene deletions experienced an additional mean annual FEV1 decline of -8.3 ml/yr, comparable to the effect of persistent smoking.
Conclusions:
- Genetic deficiency in GSTT1 is a significant determinant of accelerated lung function decline in the general male population.
- These findings highlight the role of specific genetic variations in respiratory health.
- The results contribute to understanding COPD pathogenesis and identifying at-risk individuals.
More Related Videos
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: